HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency

J Allergy Clin Immunol. 2020 Aug;146(2):447-450. doi: 10.1016/j.jaci.2020.03.043. Epub 2020 May 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Infant
  • Lymphoproliferative Disorders / therapy*
  • Male
  • Primary Immunodeficiency Diseases / therapy*
  • Treatment Outcome